Buy & Sell Regeneron Pharmaceuticals Inc (REGN) – Regeneron Pharmaceuticals Inc Price Today
Aura AI Summary
Key Stats
- $74.74BMarket Cap
- HealthSector
- -13.51%3M Drawdown
- $68.69BEnterprise Value
- 0.53%Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 96 daysTypical Hold Time
Regeneron Pharmaceuticals Inc (REGN) is currently valued at a market capitalization of $74.74B, with an enterprise value of $68.69B. Over the past 52 weeks, Regeneron Pharmaceuticals Inc has traded between a low of $483.07 and a high of $812.27, highlighting its annual price range. Over the past three months, Regeneron Pharmaceuticals Inc has recorded a drawdown of -13.51%, reflecting recent price volatility. Regeneron Pharmaceuticals Inc offers a dividend yield of 0.53%, with the most recent dividend of $0.94 paid on 20 Feb 26. On average, investors hold Regeneron Pharmaceuticals Inc for approximately 96 days, indicating typical investor behavior on the platform.
About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Most Recent News
NextEra and Dominion plan $400B merger to meet soaring AI-driven electricity demand.
NextEra Energy and Dominion Energy are in talks to merge in a deal valued around $400 billion, creating one of the largest utility companies in the U.S. This merger aims to address the rapidly growing electricity demand driven by AI data centers, ind...
Trump team ordered to discard all items from China on Air Force One amid spy fears
During President Trump's summit with Chinese President Xi Jinping, U.S. officials aboard Air Force One were instructed to discard all items received in China, including burner phones, badges, and lapel pins. This precaution addresses concerns over Ch...
iShares SHYG ETF's true yield is about 6.4%, not 7.34%, due to distressed bonds skewing the average.
The iShares 0-5 Year High Yield Corporate Bond ETF (SHYG) offers exposure to short-term USD high-yield bonds with a 2.12-year duration. While its headline yield-to-maturity (YTM) is 7.34%, this figure is misleading because it is inflated by a small p...